Third Rock Ventures San Francisco , CA 94118
Posted 4 days ago
The heart of insitro's strategy is the combination of novel, cutting edge methods in machine learning, biology at scale and small molecule discovery that address key bottlenecks in the drug development pipeline. To accomplish that, we are putting together an incredible team of discovery biologists and translational scientists who want to make a difference to this important problem. In this leadership role, you will help build the neuroscience therapeutic area (TA), hire and manage staff.
You will report to the Head of Neuroscience and work a hybrid schedule on site 3 days/week at our headquarters in South San Francisco, CA.
Your primary responsibilities will include:
You will join a growing biotech startup that has long-term stability due to significant funding, but yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact. You will work with a very experienced team, learn a broad range of skills, and help shape insitro's culture, strategic direction, and outcomes. Join us, and help make a difference to patients!
About You
PhD in technical field (Neuroscience, Genetics, etc.) with 10 years of experience in target/drug discovery in industry or academia.
A scientific track record in neuroscience or neurobiology with a focus on neurodegeneration
Experience with human genetics with a focus on target validation of genome-wide association studies
Demonstrated track record in building partnerships or collaborations with data scientists or computational biologist, engineers and experimental biologist.
Experience leading a high-performance team, including goal setting, and contributing to a culture of high-quality methods development and reducing those methods to a practical implementation
Communicate effectively and collaborate with people of diverse backgrounds and job functions, including a track record of collaborating with life scientists
Passion for making a difference in the world
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $240,000-$305,000. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
401(k) plan with employer matching for contributions
Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees on our base plans), as well as mental health and well-being support
Open, flexible vacation policy
Paid parental leave
Quarterly budget for books and online courses for self-development
Support to occasionally attend professional conferences that are meaningful to your career growth and development
New hire stipend for home office setup
Monthly cell phone & internet stipend
Access to free onsite baristas and cafe with daily lunch and breakfast
Access to free onsite fitness center
Commuter benefits
insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams-grounded in a wide range of expertise and life experiences-and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro's approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.
Third Rock Ventures